t
Haleon plc announced the results of its 2026 Annual General Meeting, held on 29 April 2026. Resolutions 20, 21, 22, and 23 were passed as special resolutions, while all other resolutions were passed as ordinary resolutions. The total votes cast for each resolution represented between approximately 84.5% and 84.8% of Haleon's issued share capital.
| Date | 29 Apr 2026 |
| Time | 16:48:06 |
| Category | AGMs and other meetings |
| ID | 4592C |
Haleon plc: Results of Haleon 2026 Annual General Meeting
29 April 2026: Haleon plc (the "Company" or "Haleon) (LSE/NYSE: HLN) announces that the following resolutions were decided by poll vote at the Company's 2026 Annual General Meeting ("AGM") which was held today.
Resolutions 20, 21, 22 and 23 were passed as special resolutions; all other resolutions were passed as ordinary resolutions. Full text of the resolutions is contained in the Company's Notice of 2026 AGM, which is available at www.haleon.com.
Haleon plc - Poll Results
|
Resolution |
Votes for |
For (% of shares voted) |
Votes against |
Against (% of shares voted) |
Total votes cast (excluding withheld) |
% of issued share capital voted1 |
Votes withheld2 |
|
|
1 |
To receive the Annual Report & Accounts |
7,518,381,689 |
99.99 |
974,818 |
0.01 |
7,519,356,507 |
84.57% |
41,371,913 |
|
2 |
To approve the Directors' Remuneration Report |
7,385,589,576 |
98.00 |
151,074,594 |
2.00 |
7,536,664,170 |
84.77% |
24,063,940 |
|
3 |
To approve the Directors' Remuneration Policy |
7,133,534,799 |
94.65 |
402,883,378 |
5.35 |
7,536,418,177 |
84.76% |
24,310,243 |
|
4 |
To declare a final dividend |
7,540,340,495 |
99.99 |
1,088,307 |
0.01 |
7,541,428,802 |
84.82% |
19,299,618 |
|
5 |
To re-elect Manvinder Singh (Vindi) Banga |
7,508,532,595 |
99.57 |
32,203,620 |
0.43 |
7,540,736,215 |
84.81% |
19,991,895 |
|
6 |
To re-elect Brian McNamara |
7,506,462,082 |
99.54 |
34,382,494 |
0.46 |
7,540,844,576 |
84.81% |
19,883,534 |
|
7 |
To re-elect Dawn Allen |
7,464,666,016 |
98.99 |
76,193,454 |
1.01 |
7,540,859,470 |
84.81% |
19,868,950 |
|
8 |
To re-elect Alan Stewart |
7,523,725,090 |
99.77 |
17,312,615 |
0.23 |
7,541,037,705 |
84.82% |
19,690,715 |
|
9 |
To re-elect Nancy Avila |
7,527,476,825 |
99.83 |
13,173,973 |
0.17 |
7,540,650,798 |
84.81% |
20,077,622 |
|
10 |
To re-elect Marie-Anne Aymerich |
7,514,059,525 |
99.84 |
11,924,672 |
0.16 |
7,525,984,197 |
84.65% |
34,743,913 |
|
11 |
To re-elect Bláthnaid Bergin |
7,535,655,488 |
99.93 |
5,031,351 |
0.07 |
7,540,686,839 |
84.81% |
20,041,582 |
|
12 |
To re-elect Tracy Clarke |
7,496,699,209 |
99.41 |
44,348,201 |
0.59 |
7,541,047,410 |
84.82% |
19,677,335 |
|
13 |
To re-elect Dame Vivienne Cox |
7,517,554,491 |
99.69 |
23,507,481 |
0.31 |
7,541,061,972 |
84.82% |
19,666,449 |
|
14 |
To re-elect Asmita Dubey |
7,536,859,688 |
99.95 |
3,756,869 |
0.05 |
7,540,616,557 |
84.81% |
20,111,863 |
|
15 |
To elect Matthew Shattock |
7,537,243,742 |
99.96 |
3,237,791 |
0.04 |
7,540,481,533 |
84.81% |
20,246,887 |
|
16 |
To re-appoint KPMG as auditor of the Company |
7,539,941,050 |
99.98 |
1,220,592 |
0.02 |
7,541,161,642 |
84.82% |
19,561,576 |
|
17 |
To authorise the Audit & Risk Committee to set the auditor's remuneration |
7,539,239,644 |
99.98 |
1,669,241 |
0.02 |
7,540,908,885 |
84.81% |
19,819,535 |
|
18 |
To authorise the Company to make political donations |
7,438,001,218 |
99.00 |
75,178,085 |
1.00 |
7,513,179,303 |
84.50% |
47,549,118 |
|
19 |
To authorise the Directors to allot ordinary shares |
7,248,168,508 |
96.12 |
292,273,298 |
3.88 |
7,540,441,806 |
84.81% |
20,286,615 |
|
20 |
General authority to disapply pre-emption rights |
7,177,724,786 |
95.20 |
361,654,667 |
4.80 |
7,539,379,453 |
84.80% |
21,348,967 |
|
21 |
Additional authority to disapply pre-emption rights |
6,995,143,055 |
92.78 |
544,236,758 |
7.22 |
7,539,379,813 |
84.80% |
21,348,334 |
|
22 |
To authorise a 14-day notice period for general meetings |
7,054,966,644 |
93.56 |
485,779,174 |
6.44 |
7,540,745,818 |
84.81% |
19,982,603 |
|
23 |
To authorise the Company to purchase its own shares |
7,533,340,747 |
99.93 |
5,392,478 |
0.07 |
7,538,733,225 |
84.79% |
21,991,442 |
1 For the purposes of section 341 of the Companies Act 2006, as at 6:30pm (BST) on Friday, 24 April 2026, Haleon's issued share capital was 8,903,405,354 ordinary shares of £0.01 each, 12,281,053 of which were held as treasury shares. Therefore, the total voting rights in the Company were 8,891,124,301.
2 A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.
As required by the UK Listing Rule 6.4.2R of the Financial Conduct Authority ("FCA"), copies of resolutions passed by the Company other than resolutions concerning ordinary business have been submitted to the FCA via the National Storage Mechanism and will shortly be available to the public for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
Amanda Mellor
Company Secretary
About Haleon
Haleon (LSE/NYSE: HLN) is a consumer company that is solely focused on better everyday health. Our people, our brands, our research, our investment and our innovation are aimed at improving the everyday health of consumers. Our product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Our superior brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are trusted by more than one billion consumers and are recommended by health professionals around the world.
For more information, please visit www.haleon.com.